PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
LABD vs. XLV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between LABD and XLV is -0.59. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.


-0.50.00.51.0-0.6

Performance

LABD vs. XLV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Health Care Select Sector SPDR Fund (XLV). The values are adjusted to include any dividend payments, if applicable.

-100.00%-50.00%0.00%50.00%100.00%150.00%JulyAugustSeptemberOctoberNovemberDecember
-99.90%
114.64%
LABD
XLV

Key characteristics

Sharpe Ratio

LABD:

-0.52

XLV:

0.47

Sortino Ratio

LABD:

-0.39

XLV:

0.71

Omega Ratio

LABD:

0.96

XLV:

1.09

Calmar Ratio

LABD:

-0.40

XLV:

0.40

Martin Ratio

LABD:

-1.07

XLV:

1.38

Ulcer Index

LABD:

37.69%

XLV:

3.74%

Daily Std Dev

LABD:

78.14%

XLV:

10.90%

Max Drawdown

LABD:

-99.97%

XLV:

-39.17%

Current Drawdown

LABD:

-99.96%

XLV:

-11.91%

Returns By Period

In the year-to-date period, LABD achieves a -24.42% return, which is significantly lower than XLV's 2.33% return.


LABD

YTD

-24.42%

1M

7.58%

6M

-3.18%

1Y

-36.04%

5Y*

-49.77%

10Y*

N/A

XLV

YTD

2.33%

1M

-4.19%

6M

-5.28%

1Y

3.36%

5Y*

7.76%

10Y*

8.97%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


LABD vs. XLV - Expense Ratio Comparison

LABD has a 1.06% expense ratio, which is higher than XLV's 0.12% expense ratio.


LABD
Direxion Daily S&P Biotech Bear 3x Shares
Expense ratio chart for LABD: current value at 1.06% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.06%
Expense ratio chart for XLV: current value at 0.12% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.12%

Risk-Adjusted Performance

LABD vs. XLV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Health Care Select Sector SPDR Fund (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for LABD, currently valued at -0.52, compared to the broader market0.002.004.00-0.520.47
The chart of Sortino ratio for LABD, currently valued at -0.39, compared to the broader market-2.000.002.004.006.008.0010.00-0.390.71
The chart of Omega ratio for LABD, currently valued at 0.96, compared to the broader market0.501.001.502.002.503.000.961.09
The chart of Calmar ratio for LABD, currently valued at -0.40, compared to the broader market0.005.0010.0015.00-0.400.40
The chart of Martin ratio for LABD, currently valued at -1.07, compared to the broader market0.0020.0040.0060.0080.00100.00-1.071.38
LABD
XLV

The current LABD Sharpe Ratio is -0.52, which is lower than the XLV Sharpe Ratio of 0.47. The chart below compares the historical Sharpe Ratios of LABD and XLV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.00JulyAugustSeptemberOctoberNovemberDecember
-0.52
0.47
LABD
XLV

Dividends

LABD vs. XLV - Dividend Comparison

LABD's dividend yield for the trailing twelve months is around 3.00%, more than XLV's 1.21% yield.


TTM20232022202120202019201820172016201520142013
LABD
Direxion Daily S&P Biotech Bear 3x Shares
3.00%6.14%0.53%0.00%3.96%1.75%0.80%0.00%0.00%0.00%0.00%0.00%
XLV
Health Care Select Sector SPDR Fund
1.21%1.59%1.47%1.33%1.49%2.17%1.58%1.47%1.60%1.43%1.35%1.52%

Drawdowns

LABD vs. XLV - Drawdown Comparison

The maximum LABD drawdown since its inception was -99.97%, which is greater than XLV's maximum drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for LABD and XLV. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-99.96%
-11.91%
LABD
XLV

Volatility

LABD vs. XLV - Volatility Comparison

Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 22.97% compared to Health Care Select Sector SPDR Fund (XLV) at 3.45%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%JulyAugustSeptemberOctoberNovemberDecember
22.97%
3.45%
LABD
XLV
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab